Physician

Tom Macek, MD

According to 2025 Medicare claims, Tom Macek, MD (NPI: 1528129988) practices anesthesiology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is M PARTNERS, LLC (NPI: 1821390899; TIN: 900635000) and primary practice location at 33334-9998.

Macek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 187 traditional Medicare patients, billed 21,050 HCPCS/CPT codes, and received $1,016,769 in Medicare payments. The top billing code was 64493 (Injection of lower or sacral spine facet joint using imaging guidance, single level). Part D data shows 5,943 prescription claims across 407 beneficiaries totaling $881,438 in drug costs, led by Relistor (Methylnaltrexone Bromide). 2021 DME data shows 19 claims. Open Payments data shows 97 records totaling $1,395. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $566,851 to $1,016,769. Similarly, Part D prescription costs have moved sharply higher in recent years, from $252,171 to $881,438. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	257	25,078	$566,851
2016	368	25,563	$618,379
2017	433	17,939	$596,419
2018	328	11,756	$648,843
2019	337	10,439	$750,720
2020	216	7,657	$592,711
2021	228	6,462	$725,923
2022	250	7,073	$702,786
2023	223	8,667	$679,628
2024	187	21,050	$1,016,769

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	246	2,734	$252,171
2016	236	2,203	$221,583
2017	266	1,533	$151,153
2018	244	1,829	$138,335
2019	294	2,553	$152,786
2020	304	3,263	$182,345
2021	331	4,023	$209,830
2022	424	6,444	$567,753
2023	453	8,474	$1,507,582
2024	407	5,943	$881,438

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	35	35	$34,470
2016	42	44	$44,510
2017	47	47	$43,220
2018	39	39	$39,731
2019	44	44	$46,880
2020	20	31	$28,193
2021	19	19	$15,075
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64493	Injection of lower or sacral spine facet joint using imaging guidance, single level	94	194	$208
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	100	355	$195
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	148	922	$68
80307	Testing for presence of drug, by chemistry analyzers	117	748	$61
J1100	Injection, dexamethasone sodium phosphate, 1 mg	135	7,017	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Relistor	Methylnaltrexone Bromide	85	2,730	$213,572
Diclofenac Sodium	Diclofenac Sodium	224	8,551	$121,371
Xtampza Er	Oxycodone Myristate	209	5,888	$83,687
Ztlido	Lidocaine	33	1,930	$68,426
Nurtec Odt	Rimegepant Sulfate	22	636	$47,298

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$1,395	Salix Pharmaceuticals, a division of Bausch Health US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tom Macek, MD?

Tedicare shows public-source Medicare data for Tom Macek, MD (NPI 1528129988), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tom Macek, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tom Macek, MD?

Tom Macek, MD is linked to M PARTNERS, LLC (billing NPI 1821390899) in the available physician profile data.

Does Tom Macek, MD have Open Payments data?

Tom Macek, MD has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.